European Metrology
Partnership website: https://www.euramet.org/research-innovation/metrology-partnership/
The European Partnership on Metrology is co-funded by the Member States and the European Union with an expected budget of around 690 million euro. The expected impact of the European Partnership on Metrology is manifold, as it will support a wide range of policies, commerce and advancement of key European challenges.
Metrology, the science of measurement, is a building block for an industrialised and increasingly globalised and digital society: Reliable measurements are essential for innovation in industry, research, trade and regulation. New societal challenges and emerging technologies increase the need for accurate, precise, and trustworthy measurements and thus for novel measurement capabilities.
The Metrology Partnership aims to support accelerating the transition towards a green, climate neutral and digital Europe, as well as strengthening the resilience, competitiveness, and economic growth of the European industry.
The Partnership builds on the progress achieved under the previous European Metrology Research Programmes, and aims to break new ground by contributing to the development of self-sustaining, coordinated metrology infrastructures, with the capacity to continue joint research and innovation after 2030.
Steering Group
The Steering Group is an advisory body of the Metrology Partnership established in accordance with Metrology Decision. It gives advice to the Metrology Partnership on the emerging priorities for metrology research at European level and on how to increase the impact of its research on European industry, economy and society.
The group will also monitor scientific achievements in specific sectors. All recommendations made by the Steering Group shall be made publicly available on the website of the European Commission.
The Steering Group is an advisory body of the Metrology Partnership established in accordance with Metrology Decision. It gives advice to the Metrology Partnership on the emerging priorities for metrology research at European level and on how to increase the impact of its research on European industry, economy and society.
Metrology partnership steering group members
Contact
Partners: EURAMET - secretariat@euramet.org
About EURAMET
EURAMET is the Regional Metrology Organisation (RMO) of Europe. They coordinate the cooperation of National Metrology Institutes (NMI) in Europe in fields such as research in metrology, traceability of measurements to the SI units, international recognition of national measurement standards and related Calibration and Measurement Capabilities (CMC). Through Knowledge Transfer and cooperation among their members EURAMET facilitates the development of the national metrology infrastructures.
What are partnerships?
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
How to use partnerships?
-
orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points. -
networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents. -
ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain. -
steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
